Doctors are actively seeking participants for a clinical research study to evaluate three increasing doses of AST-OPC1, an investigational agent for people who recently suffered a cervical (in the neck) spinal cord injury (SCI). All doses of the investigational agent must be administered at a single point in time between 14 and 30 days after injury.
Who is eligible?
Use our interactive prescreener to determine if a loved one or patient may qualify to participate in the SCiStar clinical research study. All candidates must be able to begin study screening within 25 days of their injury.